Cargando…
O9.2. ANTIPSYCHOTIC DRUGS IMPAIR BRAIN GLUCOSE SENSING RESULTING IN WHOLE BODY INSULIN RESISTANCE
BACKGROUND: Antipsychotics (APs) remain the cornerstone treatment for schizophrenia, and are widely used on- and off-label for other psychiatric disorders. However, their use presents a significant risk for serious adverse glycemic effects. Independent of changes in adiposity, APs directly dysregula...
Autores principales: | Castellani, Laura, Kowalchuk, Chantel, Asgariroozbehani, Roshanak, Tran, Veronica, Brett McIntyre, William, Hamel, Laurie, Remington, Gary, Giacca, Adria, Hahn, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233993/ http://dx.doi.org/10.1093/schbul/sbaa028.049 |
Ejemplares similares
-
T207. METABOLIC ADVERSE EFFECTS OF OFF-LABEL USE OF SECOND-GENERATION ANTIPSYCHOTICS IN THE ADULT POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Bowden, Sylvie, et al.
Publicado: (2020) -
O10.6. OLANZAPINE IMPAIRS CENTRAL INSULIN ACTION: EFFECTS ON BODY FUEL PREFERENCE IN RATS
por: Castellani, Laura, et al.
Publicado: (2018) -
O11.3. SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS
por: Chika Onwordi, Ellis, et al.
Publicado: (2020) -
F235. DIFFERENTIAL EFFECTS OF ANTIPSYCHOTICS ON NEUROINFLAMMATION AND ENERGY SENSING IN A HYPOTHALAMIC CELL LINE
por: Kowalchuk, Chantel, et al.
Publicado: (2018) -
O6.3. ASSOCIATIONS BETWEEN COGNITIVE FUNCTION AND CORTICAL LEVELS OF GLUTAMATE AND GABA IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS
por: Bojesen, Kirsten, et al.
Publicado: (2020)